Standards of Practice in Transarterial Radioembolization
暂无分享,去创建一个
Tobias F. Jakobs | Andreas H. Mahnken | Geert Maleux | Thomas Helmberger | T. Helmberger | A. Mahnken | C. Spreafico | T. Jakobs | G. Maleux | Carlo Spreafico
[1] H. Amthauer,et al. Hepatic Toxicity After Radioembolization of the Liver Using 90Y-Microspheres: Sequential Lobar Versus Whole Liver Approach , 2012, CardioVascular and Interventional Radiology.
[2] O. Solheim. [Treatment of patients with advanced cancer]. , 1973, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[3] D. Eschelman,et al. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience. , 2011, AJR. American journal of roentgenology.
[4] M. Mulcahy,et al. Incidence of Radiation Pneumonitis After Hepatic Intra-Arterial Radiotherapy With Yttrium-90 Microspheres Assuming Uniform Lung Distribution , 2008, American journal of clinical oncology.
[5] J. Juni,et al. Effects of hepatic arterial yttrium 90 glass microspheres in dogs , 1988, Cancer.
[6] S. Nag,et al. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. , 2009, International journal of radiation oncology, biology, physics.
[7] J. F. Perry,et al. Treatment of patients with advanced cancer utilizing Y90 microspheres , 1965, Cancer.
[8] A. Jemal,et al. Global Cancer Statistics , 2011 .
[9] A. Benson,et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. , 2011, Gastroenterology.
[10] M. Reiser,et al. Radioembolization of Symptomatic, Unresectable Neuroendocrine Hepatic Metastases Using Yttrium-90 Microspheres , 2012, CardioVascular and Interventional Radiology.
[11] C. Nutting,et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. , 2006, International journal of radiation oncology, biology, physics.
[12] A. Benson,et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. , 2010, Gastroenterology.
[13] A. Benson,et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. , 2007, International journal of radiation oncology, biology, physics.
[14] N. Obuchowski,et al. Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma. , 2011, Journal of vascular and interventional radiology : JVIR.
[15] S. Houle,et al. A phase I dose escalation trial of yttrium‐90 microspheres in the treatment of primary hepatocellular carcinoma , 1992, Cancer.
[16] R. Salem,et al. Radiation pneumonitis following yttrium-90 radioembolization: case report and literature review. , 2012, Journal of vascular and interventional radiology : JVIR.
[17] Daniel Normolle,et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. , 2002, International journal of radiation oncology, biology, physics.
[18] D. Morris,et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases , 2008, Cancer.
[19] C. Kuhl,et al. The Significance of 99mTc-MAA SPECT/CT Liver Perfusion Imaging in Treatment Planning for 90Y-Microsphere Selective Internal Radiation Treatment , 2010, The Journal of Nuclear Medicine.
[20] A. Benson,et al. 90Y Radioembolization for Metastatic Neuroendocrine Liver Tumors: Preliminary Results From a Multi-institutional Experience , 2008, Annals of surgery.
[21] C. Nutting,et al. Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. , 2007, International journal of radiation oncology, biology, physics.
[22] J. Ertle,et al. Radioembolization with yttrium‐90 glass microspheres in hepatocellular carcinoma: European experience on safety and long‐term survival , 2010, Hepatology.
[23] Ariel Im,et al. The treatment of cancer metastases in the lung by means of radiating microspheres. , 1966 .
[24] R. Goldberg,et al. TREATMENT OF METASTATIC COLORECTAL CANCER Review of recent advances , 2005 .
[25] C. Nutting,et al. Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients , 2008, American journal of clinical oncology.
[26] D. Morris,et al. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases , 2010, The British journal of surgery.
[27] R. Murthy,et al. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. , 2007, Journal of vascular and interventional radiology : JVIR.
[28] D. Sze,et al. Research reporting standards for radioembolization of hepatic malignancies. , 2011, Journal of vascular and interventional radiology : JVIR.
[29] Tushar C. Barot,et al. The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[30] A. Benson,et al. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis , 2007, Hepatology.
[31] R. T. Ten Haken,et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] D. Larsimont,et al. Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres. , 2008, Clinical nuclear medicine.
[33] Kenneth G. Thurston,et al. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. , 2010, Journal of vascular and interventional radiology : JVIR.
[34] P. Aspelin,et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines , 2011, European Radiology.
[35] I. Kamel,et al. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. , 2009, Journal of vascular and interventional radiology : JVIR.
[36] J. Prieto,et al. A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma. , 2009, Hepato-gastroenterology.
[37] R. Stubbs,et al. SELECTIVE INTERNAL RADIATION THERAPY WITH 90Y MICROSPHERES FOR COLORECTAL LIVER METASTASES: SINGLE‐CENTRE EXPERIENCE WITH 100 PATIENTS , 2006, ANZ journal of surgery.
[38] F. Izzo,et al. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases , 2010, British Journal of Cancer.
[39] Kenneth G. Thurston,et al. Angiographic considerations in patients undergoing liver-directed therapy. , 2005, Journal of vascular and interventional radiology : JVIR.
[40] N. Pavlakis,et al. Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres. , 2010, Journal of vascular and interventional radiology : JVIR.
[41] V. Gebski,et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[42] M. Reiser,et al. Radioembolization in patients with hepatic metastases from breast cancer. , 2008, Journal of vascular and interventional radiology : JVIR.
[43] M. A. Bosch,et al. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis , 2009, European Radiology.
[44] F. Izzo,et al. Survival after yttrium‐90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation , 2011, Hepatology.
[45] G. van Hazel,et al. Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer , 2004, Journal of surgical oncology.
[46] W. Gradishar,et al. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. , 2007, Journal of vascular and interventional radiology : JVIR.
[47] E. Van Cutsem,et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] M. Mulcahy,et al. Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. , 2009, Journal of vascular and interventional radiology : JVIR.
[49] E. Felix,et al. Intraarterial yttrium 90 in the treatment of hepatic malignancy. , 1982, Radiology.
[50] A. Benson,et al. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. , 2008, Radiology.
[51] G. Pack,et al. The Treatment of Cancer Metastases in the Lung by means of Radiating Microspheres* , 1966, Thoraxchirurgie und vaskulare Chirurgie.
[52] T. Chua,et al. Factors Predicting Response and Survival After Yttrium-90 Radioembolization of Unresectable Neuroendocrine Tumor Liver Metastases: A Critical Appraisal of 48 Cases , 2010, Annals of surgery.
[53] T. Chua,et al. Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases , 2011, Journal of Cancer Research and Clinical Oncology.
[54] Donald L. Miller,et al. Society of Interventional Radiology clinical practice guidelines. , 2009, Journal of vascular and interventional radiology : JVIR.
[55] Riccardo Lencioni,et al. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.
[56] A. Benson,et al. Radioembolization of colorectal hepatic metastases using yttrium‐90 microspheres , 2009, Cancer.